Anúncio
relacionado a: 23andMeDiscover The Story Of Your Historic Ancestors And Find Out Your Lost Family Members. 23 And Me DNA Kits? Try Other And Better Alternatives. Top Rated DNA Ancestry Testing Kits
- Visit Website
Get Your Family Tree
Online Today!
- Top DNA Tests In 2024
Compare And Choose The Best Kits
Order DNA test As a Gift Or For You
- Ancestry DNA Tests
Find The Best Ancestry DNA
Tests-Easy, Easy And Secure
- DNA Kits Deals
Great Deals On DNA Kits.-Find The
Best Deals Today!
- Ancestry DNA Review 2024
Discover Your History
Meet Your Extended Family
- Family Tree Maker
Create your own family tree today.
Easy to use and easy to use.
- Visit Website
Resultado da Busca
1 de mai. de 2024 · This is a scam. I was sent a kit and after providing my sample and following the return directions and not hearing anything after a few months, I reached out to the company. They asked me to provide my name and 3 out of 7 identifying factors. I provided my name and 4 out of the 7 factors. They said they have no kit matching those factors.
Há 2 dias · Get 23andMe Holding Co. (ME.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments
21 de mai. de 2024 · 23andMe Holding Co. (NASDAQ:ME - Get Free Report) insider Kathy L. Hibbs sold 38,551 shares of the business's stock in a transaction dated Thursday, May 2nd. The shares were sold at an average price of $0.49, for a total transaction of $18,889.99. Following the completion of the transaction, the insider now owns 1,252,315 shares in the company ...
Há 6 dias · SOUTH SAN FRANCISCO, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and biopharmaceutical company, reported its financial results for the fourth quarter and full year of fiscal year 2024 (FY24), which ended March 31, 2024.
22 de mai. de 2024 · Citigroup Adjusts 23andMe Price Target to $0.47 From $0.85, Maintains Neutral Rating. Apr. 16. MT. Citigroup Adjusts 23andMe Holding's Price Target to $1.75 From $2.50, Keeps Buy Rating. 23-08-10. MT. Citigroup Adjusts 23andMe Price Target to $2.50 From $3.75, Maintains Neutral Rating. 23-05-26.
Há 6 dias · 23andMe Holding Co. is a genetics-led consumer healthcare and therapeutics company. The Company operates through two segments: Consumer & Research Services and Therapeutics. The Consumer & Research Services business segment comprises its Personal Genome Service (PGS), telehealth business, and research service.
Há 4 dias · 캘리포니아주 서니베일, 2024년 5월 14일 (GLOBE NEWSWIRE) -- 23andMe Holding Co.(Nasdaq: ME)의 자회사이자 선도적인 원격 의료 제공업체인 Lemonaid Health, Inc.가 이제 Petros Pharmaceuticals, Inc.를
